top of page
New Alzheimer’s Drug and Considerations for State I/DD Agencies: Aducanumab: Panacea or Risk for Adults with Down Syndrome
Conference presentation
Virtual presentation on aducanumab and implications for state I/DD agencies to the Medical & Clinical Director's Work Group of the National Association of State Directors of Developmental Disabilities Services on August 4, 2021
bottom of page